Literature DB >> 23375418

Procalcitonin as diagnostic biomarker of sepsis.

Arash Afshari1, Stephan Harbarth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23375418     DOI： 10.1016/S1473-3099(13)70026-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  6 in total

Review 1.  Gene Expression Profiles in Children With Suspected Sepsis.

Authors:  Fran Balamuth; Elizabeth R Alpern; Mengyuan Kan; Maya Shumyatcher; Katie Hayes; Ebbing Lautenbach; Blanca E Himes
Journal:  Ann Emerg Med       Date:  2020-01-23       Impact factor: 5.721

Review 2.  Procalcitonin: present and future.

Authors:  H H Liu; J B Guo; Y Geng; L Su
Journal:  Ir J Med Sci       Date:  2015-07-10       Impact factor: 1.568

Review 3.  Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.

Authors:  Werner C Albrich; Stephan Harbarth
Journal:  Intensive Care Med       Date:  2015-07-21       Impact factor: 17.440

4.  Nomograms Predicting the Occurrence of Sepsis in Patients following Major Hepatobiliary and Pancreatic Surgery.

Authors:  Haoyun Zhang; Fanyu Meng; Shichun Lu
Journal:  Gastroenterol Res Pract       Date:  2020-08-01       Impact factor: 2.260

5.  Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3.

Authors:  Dong Wook Jekarl; Seungok Lee; Myungshin Kim; Yonggoo Kim; Seon Hee Woo; Woon Jeong Lee
Journal:  J Clin Lab Anal       Date:  2019-08-16       Impact factor: 2.352

Review 6.  Viral Sepsis in Children.

Authors:  Neha Gupta; Robert Richter; Stephen Robert; Michele Kong
Journal:  Front Pediatr       Date:  2018-09-18       Impact factor: 3.418
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.